Table 3.
Viruses used in validation studies
| Virus | Number of studies |
|---|---|
| PRV | 117 |
| BVDV | 109 |
| HIV‐1 | 53 |
| SINV | 9 |
| EAV | 7 |
| WNV | 6 |
| VSV | 4 |
| VacV | 2 |
| SARS‐CoV | 1 |
| Total | 308 |
Viruses used in validation studies
| Virus | Number of studies |
|---|---|
| PRV | 117 |
| BVDV | 109 |
| HIV‐1 | 53 |
| SINV | 9 |
| EAV | 7 |
| WNV | 6 |
| VSV | 4 |
| VacV | 2 |
| SARS‐CoV | 1 |
| Total | 308 |